πŸ‡ΊπŸ‡Έ FDA
Patent

US 9931412

Targeted theranostics

granted A61KA61K47/551A61K47/64

Quick answer

US patent 9931412 (Targeted theranostics) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/551, A61K47/64, A61K47/644, A61K47/65